# Denali Therapeutics Inc. (DNLI) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$513M |
| 2024 | -$423M |
| 2023 | -$145M |
| 2022 | -$326M |
| 2021 | -$291M |
| 2020 | $71M |
| 2019 | -$198M |
| 2018 | -$36M |
| 2017 | -$88M |
| 2016 | -$87M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2024-09-30 | -$107M |
| 2024-06-30 | -$99M |
| 2024-03-31 | -$102M |
| 2023-09-30 | -$99M |
| 2023-06-30 | $183M |
| 2023-03-31 | -$110M |
| 2022-09-30 | -$103M |
| 2022-06-30 | -$59M |
| 2022-03-31 | -$65M |
| 2021-09-30 | -$85M |
| 2021-06-30 | -$61M |
| 2021-03-31 | -$70M |
| 2020-09-30 | -$58M |
| 2020-06-30 | -$59M |
| 2020-03-31 | -$57M |
| 2019-09-30 | -$46M |
| 2019-06-30 | -$58M |
| 2019-03-31 | -$39M |
| 2018-09-30 | -$35M |
| 2018-06-30 | -$55M |
| 2018-03-31 | -$24M |
| 2017-09-30 | -$22M |
| 2017-06-30 | -$22M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/DNLI/net-income)